openPR Logo
Press release

Colorectal Cancer Screening Market Is Booming So Rapidly 2025-2032 - Polymedco Inc, Eiken Chemical Co. Ltd.

07-30-2025 04:11 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Colorectal Cancer Screening Market

Colorectal Cancer Screening Market

The colorectal cancer screening market is poised for significant growth as rising awareness about early cancer detection and technological advancements continue to drive the adoption of innovative screening methods. The growing global burden of colorectal cancer, coupled with increasing healthcare expenditure and enhanced screening infrastructure, is amplifying the demand for effective screening solutions across healthcare institutions and diagnostic centers. Furthermore, supportive government initiatives to promote regular screening and improved reimbursement policies are accelerating market penetration in developed and emerging economies alike. The Global Colorectal Cancer Screening Market size is estimated to be valued at USD 16.57 billion in 2025 and is expected to reach USD 27.15 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/5098

➤Analyst Opinion

● Increasing Adoption of Non-Invasive Screening Methods: The shift toward non-invasive diagnostic tools such as stool DNA tests and immunochemical fecal occult blood tests (iFOBT) has been a key driver for market expansion. Data from 2024 reveals a 22% increase in demand for such methods compared to invasive colonoscopies, aligning with patient preference for less discomfort and reduced risk. This trend is expected to contribute significantly to the colorectal cancer screening market size and scope in the coming years.

● Rising Incidence Rates in Emerging Economies: Epidemiological studies published in 2025 underscore a 15% annual increase in colorectal cancer cases across Asia Pacific, notably in China and India. This rising incidence fuels demand for screening programs, thereby impacting market revenue positively. Enhanced screening adoption in these regions is a crucial demand-side indicator influencing market growth strategies.

● Technological Innovation and Integration: The integration of artificial intelligence (AI) and machine learning in screening technologies has enhanced diagnostic accuracy and efficiency. For example, AI-powered colonoscopy systems reported a 30% higher polyp detection rate in clinical trials conducted in 2024, boosting healthcare providers' inclination to invest in advanced screening equipment. This supply-side capability is shaping market players' product development and capital expenditure decisions.

● Expanding Preventive Healthcare Policies: Several governments globally have mandated colorectal cancer screening as part of national health policy, thereby amplifying market demand. According to World Health Organization data from early 2025, countries with enforced screening protocols witnessed a 12% increase in early colorectal cancer detection rates, directly correlating with increased colorectal cancer screening market share and adoption rates.

➤Market Taxonomy and Regional coverage of Report

● Comprehensive Taxonomy of the Report:

» By Product Type: Colonoscopy, Stool DNA Tests, Fecal Immunochemical Test (FIT), Sigmoidoscopy, Others
» By End-User: Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Others
» By Screening Type: Routine Screening, Diagnostic Screening, Surveillance Screening, Others

● Regional and Country Analysis:

» North America: U.S. and Canada
» Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
» Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
» Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
» Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/5098

➤Leading Companies of the Market

● Polymedco Inc.
● Eiken Chemical Co. Ltd.
● Sysmex Corporation
● Siemens Healthineers AG
● Quidel Corporation
● Novigenix SA
● Hemosure Inc.
● Exact Sciences Corp.
● Epigenomics Inc.
● Olympus Corporation
● Clinical Genomics Technologies Pty Ltd.
● Guardant Health, Inc.
● Geneoscopy, Inc.

● Several leading market players focus on expanding their geographic footprint through strategic collaborations and acquisitions. For instance, Exact Sciences Corporation's acquisition of Clinical Genomics in 2024 enhanced their CRC screening portfolio, leading to a 17% increase in market revenue last year. Similarly, Siemens Healthineers AG's partnership with digital health startups has accelerated the integration of AI-driven diagnostics, resulting in improved product differentiation and competitive advantage.

➤Key Growth Drivers Fueling Market Expansion

Key market drivers include the rising colorectal cancer prevalence globally, which has necessitated early and routine screenings. The increasing geriatric population, frequently affected by colorectal cancers, is another critical growth factor, with the UN reporting a global population aged 65 and above growing by 9% annually in 2025. Technological advancements are propelling market growth strategically-novel liquid biopsy tests and enhanced imaging techniques have improved diagnostic sensitivity, fostering higher adoption rates. Additionally, expanding healthcare infrastructure in emerging regions, supported by government initiatives promoting preventive screenings, is broadening market scope, providing a strong impetus to the colorectal cancer screening market growth strategies.

➤Key Reasons for Buying the Colorectal Cancer Screening Market Report

✦ Comprehensive analysis of the changing competitive landscape
✦ Assists in decision-making processes for the businesses along with detailed strategic planning methodologies
✦ The report offers forecast data and an assessment of the colorectal cancer screening market
✦ Helps in understanding the key product segments and their estimated growth rate
✦ In-depth analysis of market drivers, restraints, trends, and opportunities
✦ Comprehensive regional analysis of the colorectal cancer screening market
✦ Extensive profiling of the key stakeholders of the business sphere
✦ Detailed analysis of the factors influencing the growth of the colorectal cancer screening market

➤ Emerging Trends and Market Shift

The colorectal cancer screening market is witnessing a paradigm shift from invasive to non-invasive methods, driven by enhanced patient compliance and faster turnaround times. Additionally, integration of digital health technologies such as remote monitoring and telehealth platforms in screening workflows is gaining momentum, providing scalable solutions amidst healthcare resource constraints noted in 2024 across North America and Europe. Furthermore, precision medicine and biomarker-driven screening protocols are emerging trends, enabling personalized screening schedules that optimize early detection rates and reduce healthcare costs. This evolution is contributing to evolving market dynamics and reshaping competitive strategies among leading players.

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/5098

➤High-Impact Market Opportunities by Segment and Region

Opportunities abound in the stool DNA test segment, which is forecasted to register double-digit growth due to its non-invasive nature and high diagnostic accuracy-a recent study in 2025 reported a 44% increase in utilization in outpatient diagnostics. In terms of end-user segments, ambulatory surgical centers are expanding their colorectal screening services, driven by increased patient preference for outpatient procedures and cost efficiency, creating lucrative avenues for device manufacturers. Regionally, Asia Pacific represents a high-impact opportunity due to burgeoning healthcare infrastructure investments and rising colorectal cancer awareness. China alone is projected to witness a CAGR of over 9% between 2025 and 2032, underpinned by government-led national screening initiatives and expanding insurance coverage.

❓ Frequently Asked Questions

1. Who are the dominant players in the colorectal cancer screening market?
The market is led by companies including Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, and Exact Sciences Corp., all of which have extensive portfolios and strategic expansions supporting their market leadership.

2. What will be the size of the colorectal cancer screening market in the coming years?
The colorectal cancer screening market is expected to increase from USD 16.57 billion in 2025 to USD 27.15 billion by 2032, growing at a CAGR of 7.3% during the forecast period.

3. Which end-user industry has the largest growth opportunity?
Hospitals remain the largest end-user segment due to their comprehensive screening capabilities; however, ambulatory surgical centers and diagnostic laboratories are rapidly expanding, presenting high growth potential driven by cost-effectiveness and patient preference.

4. How will market development trends evolve over the next five years?
Market trends indicate a transition towards non-invasive screening technologies, boosted by AI integration and personalized medicine approaches that will enhance screening accuracy and patient compliance globally.

5. What is the nature of the competitive landscape and challenges in the colorectal cancer screening market?
The market is marked by continuous innovation and strategic partnerships. Challenges include reimbursement complexities and regulatory approvals, which require agile market growth strategies for sustainable business growth.

6. What go-to-market strategies are commonly adopted in the colorectal cancer screening market?
Leading market players often adopt strategies such as mergers and acquisitions, geographic expansion, product portfolio diversification, and strategic collaborations with healthcare providers to maintain and grow their market share.

✍️ PR Authored By:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report.

About Us:

With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries

☎️ Contact Us:

533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-8-7924-7805
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com☎️ Contact Us:

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Screening Market Is Booming So Rapidly 2025-2032 - Polymedco Inc, Eiken Chemical Co. Ltd. here

News-ID: 4126870 • Views:

More Releases from Coherent Market Insights

Crispr Technology Market Generated Opportunities, Future Scope 2025-2032 | Merck KGaA, Thermo Fisher Scientific, Origene Technologies
Crispr Technology Market Generated Opportunities, Future Scope 2025-2032 | Merck …
The global CRISPR technology market is estimated to be valued at USD 3,656.2 Mn in 2025 and is expected to exhibit a CAGR of 19.4% during the forecast period (2025-2032). The Crispr Technology Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying
Pet Diabetes Care Devices Market Future Business Opportunities 2025-2032 | Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services
Pet Diabetes Care Devices Market Future Business Opportunities 2025-2032 | Abbot …
The global pet diabetes care devices market is estimated to be valued at USD 2.60 Bn in 2025 and is expected to reach USD 4.26 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. The Pet Diabetes Care Devices Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market
Protein Chip Market Future Business Opportunities 2025-2032 | Agilent Technologies, PerkinElmer, Bio-Rad Laboratories
Protein Chip Market Future Business Opportunities 2025-2032 | Agilent Technologi …
The Global Protein Chip Market is estimated to be valued at USD 2.39 Bn in 2025 and is expected to reach USD 3.86 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. The Protein Chip Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth
In Vivo CRO Market Growth in Future Scope 2025-2032 | IQVIA Inc., Crown Bioscience, Taconic Biosciences, Inc., PsychoGenics Inc
In Vivo CRO Market Growth in Future Scope 2025-2032 | IQVIA Inc., Crown Bioscien …
The global in vivo CRO market is estimated to be valued at USD 5.11 Bn in 2025 and is expected to reach USD 9.17 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032. The In Vivo CRO Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as

All 5 Releases


More Releases for Screening

Screening Success: High-Throughput Screening (HTS) Market Insights (2023-2033)
Market Outlook: The High-Throughput Screening (HTS) Market is poised for significant growth, playing a pivotal role in accelerating drug discovery and development processes. With advancements in automation, assay technologies, and a focus on identifying potential drug candidates efficiently, the market anticipates robust expansion in the adoption of high-throughput screening methodologies. The outlook is characterized by a surge in demand for rapid and cost-effective screening solutions, the integration of artificial intelligence
Carrier Screening Market: Genetic Health Screening on the Rise | CAGR 13.8%
Allied Market Research recently released 'Global Carrier Screening Market: Outlook and Forecast 2023-2030.' This comprehensive report assesses market risks, identifies emerging opportunities, and offers valuable strategic and tactical decision-making support for the period spanning 2023 to 2030. The market study is thoughtfully segmented by key regions that are pivotal for driving market growth. This report presents insights into market research and development, explores growth drivers, and delves into the evolving
Alcohol Screening Breathalyzer and Alcohol Screening Device Manufacturer | ALCOF …
ALCOFIND, a DA Tech brand, is a trustworthy and flawless maker of alcohol screening breathalyzer. It includes both an advanced alcohol tester and an alcohol screening device.  DA Tech has dedicated itself to the research and development of sensor-related application solutions since its foundation in 2002, firmly establishing itself as a specialized breathalyser company and emerging as a global leader. ALCOFIND breathalyser has quality certifications for the world's major breathalyser markets, including
Cancer Screening Technology Market Update and Forecast to 2025; Breast Cancer Sc …
The Cancer Screening Technology Market recently Published Global Market research study with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed TOC on “Cancer Screening Technology Market”. The report provides information and the advancing business series information in the sector to the exchange. The report provides a notion connected to the progress of this market movement of significant players of this industry. An examination
Prenatal Screening Market | Global Industry Analysis by First-Trimester Screenin …
Prenatal Screening market 2020 with industry size, share, trends, growth, opportunities, key players and forecast by 2025.The global Prenatal Screening market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. Supply Demand Market Research's latest publication, titled global Prenatal Screening market, offers an insightful take on the drivers and restraints present in
Background Screening Market -Sterling Infosystems, First Aduvatage, HireRight, K …
Background Screening Market Overview: Summary:Background Screening is the process of looking up and compiling criminal records, commercial records, and financial records of an individual or an organization. Background Screening is often requested by employers on job candidates for employment screening, especially on candidates seeking a position that requires high security or a position of trust, such as in a school, courthouse, hospital, financial institution, airport, and government. These checks are traditionally